Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

Prognostic CT findings of malignant bowel obstruction in patients with advanced ovarian cancer.

Miccò M, Sbarra M, Gui B, Bianco NC, Rodolfino E, Manfredi R.

Tumori. 2019 Nov 18:300891619886657. doi: 10.1177/0300891619886657. [Epub ahead of print]

PMID:
31739760
2.

Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected European Centers.

Ruggeri M, Pagan E, Bagnardi V, Bianco N, Gallerani E, Buser K, Giordano M, Gianni L, Rabaglio M, Freschi A, Cretella E, Clerico M, Farolfi A, Simoncini E, Ciccarese M, Rauch D, Ramello M, Glaus A, Berardi R, Pellanda AF, Ribi K, Gelber S, Partridge AH, Goldhirsch A, Pagani O.

Breast. 2019 Oct;47:85-92. doi: 10.1016/j.breast.2019.07.001. Epub 2019 Jul 10.

PMID:
31362134
3.

Wearable Cardioverter Defibrillator-Guided 6-Min Walk Test Performed at Home Is Accurate and Reliable: RESULTS OF THE TRENDS STUDY.

Burch AE, Scherr D, Rieth A, Griffin J, Bianco NR, Odeneg T, Sears SF.

J Cardiopulm Rehabil Prev. 2019 Jul 22. doi: 10.1097/HCR.0000000000000441. [Epub ahead of print]

PMID:
31343585
4.

Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines.

Munzone E, Bagnardi V, Campennì G, Mazzocco K, Pagan E, Tramacere A, Masiero M, Iorfida M, Mazza M, Montagna E, Cancello G, Bianco N, Palazzo A, Cardillo A, Dellapasqua S, Sangalli C, Pettini G, Pravettoni G, Colleoni M, Veronesi P.

Br J Cancer. 2019 Aug;121(4):325-331. doi: 10.1038/s41416-019-0520-8. Epub 2019 Jul 15.

PMID:
31303642
5.

Boundary layer considerations in a multi-layer model for LDL accumulation.

Iasiello M, Vafai K, Andreozzi A, Bianco N.

Comput Methods Biomech Biomed Engin. 2018 Nov;21(15):803-811. doi: 10.1080/10255842.2018.1521963. Epub 2018 Nov 6.

PMID:
30398068
6.

Long-term use of the wearable cardioverter defibrillator in patients with explanted ICD.

Kaspar G, Sanam K, Gholkar G, Bianco NR, Szymkiewicz S, Shah D.

Int J Cardiol. 2018 Dec 1;272:179-184. doi: 10.1016/j.ijcard.2018.08.017. Epub 2018 Aug 10.

PMID:
30121177
7.

The US Experience of the Wearable Cardioverter-Defibrillator in Pediatric Patients.

Spar DS, Bianco NR, Knilans TK, Czosek RJ, Anderson JB.

Circ Arrhythm Electrophysiol. 2018 Jul;11(7):e006163. doi: 10.1161/CIRCEP.117.006163.

PMID:
29945928
8.

Outcomes after asystole events occurring during wearable defibrillator-cardioverter use.

Liang JJ, Bianco NR, Muser D, Enriquez A, Santangeli P, D'Souza BA.

World J Cardiol. 2018 Apr 26;10(4):21-25. doi: 10.4330/wjc.v10.i4.21.

9.

Analysis of non-Newtonian effects within an aorta-iliac bifurcation region.

Iasiello M, Vafai K, Andreozzi A, Bianco N.

J Biomech. 2017 Nov 7;64:153-163. doi: 10.1016/j.jbiomech.2017.09.042. Epub 2017 Oct 13.

PMID:
29100596
10.

Can Measured Synergy Excitations Accurately Construct Unmeasured Muscle Excitations?

Bianco NA, Patten C, Fregly BJ.

J Biomech Eng. 2018 Jan 1;140(1). doi: 10.1115/1.4038199.

PMID:
29049521
11.

National experience with long-term use of the wearable cardioverter defibrillator in patients with cardiomyopathy.

Lamichhane M, Gardiner JC, Bianco NR, Szymkiewicz SJ, Thakur RK.

J Interv Card Electrophysiol. 2017 Jan;48(1):11-19. doi: 10.1007/s10840-016-0194-6. Epub 2016 Oct 17.

PMID:
27752809
12.

Analysis of non-Newtonian effects on Low-Density Lipoprotein accumulation in an artery.

Iasiello M, Vafai K, Andreozzi A, Bianco N.

J Biomech. 2016 Jun 14;49(9):1437-1446. doi: 10.1016/j.jbiomech.2016.03.017. Epub 2016 Mar 17.

PMID:
27055766
13.

The Wearable Cardioverter Defibrillator in Nonischemic Cardiomyopathy: A US National Database Analysis.

Salehi N, Nasiri M, Bianco NR, Opreanu M, Singh V, Satija V, Jhand AS, Karapetyan L, Safadi AR, Surapaneni P, Thakur RK.

Can J Cardiol. 2016 Oct;32(10):1247.e1-1247.e6. doi: 10.1016/j.cjca.2015.12.035. Epub 2016 Jan 14.

PMID:
26975224
14.

Low-density lipoprotein transport through an arterial wall under hyperthermia and hypertension conditions--An analytical solution.

Iasiello M, Vafai K, Andreozzi A, Bianco N.

J Biomech. 2016 Jan 25;49(2):193-204. doi: 10.1016/j.jbiomech.2015.12.015. Epub 2015 Dec 11.

PMID:
26806687
15.

Transcrestal maxillary sinus augmentation: Summers' versus a piezoelectric technique--an experimental cadaver study.

Kühl S, Kirmeier R, Platzer S, Bianco N, Jakse N, Payer M.

Clin Oral Implants Res. 2016 Jan;27(1):126-9. doi: 10.1111/clr.12546. Epub 2015 Feb 16.

PMID:
25682786
16.

Effects of External and Internal Hyperthermia on LDL Transport and Accumulation Within an Arterial Wall in the Presence of a Stenosis.

Iasiello M, Vafai K, Andreozzi A, Bianco N, Tavakkoli F.

Ann Biomed Eng. 2015 Jul;43(7):1585-99. doi: 10.1007/s10439-014-1196-0. Epub 2014 Dec 18.

PMID:
25520050
17.

Activity of a three-drug combination including cisplatin (CLOVER regimen) for poorly differentiated neuroendocrine carcinoma.

Bajetta E, Catena L, Biondani P, Pusceddu S, Valente M, Bianco N, Novelli E.

Anticancer Res. 2014 Oct;34(10):5657-60.

PMID:
25275070
18.

Everolimus in combination with octreotide long-acting repeatable in a first-line setting for patients with neuroendocrine tumors: an ITMO group study.

Bajetta E, Catena L, Fazio N, Pusceddu S, Biondani P, Blanco G, Ricci S, Aieta M, Pucci F, Valente M, Bianco N, Mauri CM, Spada F.

Cancer. 2014 Aug 15;120(16):2457-63. doi: 10.1002/cncr.28726. Epub 2014 Apr 18.

19.

Single agent panitumumab in KRAS wild-type metastatic colorectal cancer patients following cetuximab-based regimens: Clinical outcome and biomarkers of efficacy.

Pietrantonio F, Perrone F, Biondani P, Maggi C, Lampis A, Bertan C, Venturini F, Tondulli L, Ferrari D, Ricci V, Villa F, Barone G, Bianco N, Ghidini A, Bossi I, Fanetti G, Di Bartolomeo M, de Braud F.

Cancer Biol Ther. 2013 Dec;14(12):1098-103. doi: 10.4161/cbt.26343. Epub 2013 Sep 4.

20.

Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.

Epstein AE, Abraham WT, Bianco NR, Kern KB, Mirro M, Rao SV, Rhee EK, Solomon SD, Szymkiewicz SJ.

J Am Coll Cardiol. 2013 Nov 19;62(21):2000-2007. doi: 10.1016/j.jacc.2013.05.086. Epub 2013 Jul 31.

21.

Surgical correction of "rhinoplastic look".

Sciuto S, Bianco N.

Acta Otorhinolaryngol Ital. 2013 Jun;33(3):177-82.

22.

Wearable defibrillator use in heart failure (WIF): results of a prospective registry.

Kao AC, Krause SW, Handa R, Karia D, Reyes G, Bianco NR, Szymkiewicz SJ; Wearable defibrillator use In heart Failure (WIF) Investigators.

BMC Cardiovasc Disord. 2012 Dec 12;12:123. doi: 10.1186/1471-2261-12-123.

23.

New perspectives in the treatment of neuroendocrine tumours.

Bajetta E, Catena L, Valente M, Bianco N, Bellomo F, Bombardieri E.

Anticancer Res. 2012 Oct;32(10):4193-200. Review.

PMID:
23060539
24.

Respiratory mechanics during repeated lung lavages in pulmonary alveolar proteinosis.

Antonaglia V, Ferluga M, Bianco N, Accolla PP, Zin WA.

Intern Emerg Med. 2012 Sep;7 Suppl 2:S109-11. doi: 10.1007/s11739-012-0767-z. Epub 2012 Mar 17. No abstract available.

PMID:
22426811
25.

Characteristics and outcomes of peripartum versus nonperipartum cardiomyopathy in women using a wearable cardiac defibrillator.

Saltzberg MT, Szymkiewicz S, Bianco NR.

J Card Fail. 2012 Jan;18(1):21-7. doi: 10.1016/j.cardfail.2011.09.004. Epub 2011 Oct 19.

PMID:
22196837
26.

Wearable defibrillator in congenital structural heart disease and inherited arrhythmias.

Rao M, Goldenberg I, Moss AJ, Klein H, Huang DT, Bianco NR, Szymkiewicz SJ, Zareba W, Brenyo A, Buber J, Barsheshet A.

Am J Cardiol. 2011 Dec 1;108(11):1632-8. doi: 10.1016/j.amjcard.2011.07.021. Epub 2011 Sep 3.

PMID:
21890075
27.

Tumor-derived exosomes confer antigen-specific immunosuppression in a murine delayed-type hypersensitivity model.

Yang C, Kim SH, Bianco NR, Robbins PD.

PLoS One. 2011;6(8):e22517. doi: 10.1371/journal.pone.0022517. Epub 2011 Aug 2.

28.

Changes in microvascular blood flow during coupled plasma filtration and adsorption.

Berlot G, Bianco N, Tomasini A, Vassallo MC, Bianco F.

Anaesth Intensive Care. 2011 Jul;39(4):687-9.

29.

The visual hemifield asymmetry in the spatial blink during singleton search and feature search.

Burnham BR, Rozell CA, Kasper A, Bianco NE, Delliturri A.

Brain Cogn. 2011 Apr;75(3):261-72. doi: 10.1016/j.bandc.2011.01.003. Epub 2011 Feb 4.

PMID:
21295901
30.

Serum adipokine levels in patients with systemic lupus erythematosus.

De Sanctis JB, Zabaleta M, Bianco NE, Garmendia JV, Rivas L.

Autoimmunity. 2009 May;42(4):272-4.

PMID:
19811274
31.
32.

B7-1/2, but not PD-L1/2 molecules, are required on IL-10-treated tolerogenic DC and DC-derived exosomes for in vivo function.

Ruffner MA, Kim SH, Bianco NR, Francisco LM, Sharpe AH, Robbins PD.

Eur J Immunol. 2009 Nov;39(11):3084-90. doi: 10.1002/eji.200939407.

33.
34.

Genetic contribution of major histocompatibility complex class II region to type 1 autoimmune hepatitis susceptibility in Venezuela.

Fortes Mdel P, Machado IV, Gil G, Fernández-Mestre M, Dagher L, León RV, Bianco NE, Tassinari P.

Liver Int. 2007 Dec;27(10):1409-16. Epub 2007 Oct 9.

PMID:
17927716
35.

Modulation of the immune response using dendritic cell-derived exosomes.

Bianco NR, Kim SH, Morelli AE, Robbins PD.

Methods Mol Biol. 2007;380:443-55. Review.

PMID:
17876111
36.

Effective treatment of inflammatory disease models with exosomes derived from dendritic cells genetically modified to express IL-4.

Kim SH, Bianco NR, Shufesky WJ, Morelli AE, Robbins PD.

J Immunol. 2007 Aug 15;179(4):2242-9.

37.

MHC class II+ exosomes in plasma suppress inflammation in an antigen-specific and Fas ligand/Fas-dependent manner.

Kim SH, Bianco NR, Shufesky WJ, Morelli AE, Robbins PD.

J Immunol. 2007 Aug 15;179(4):2235-41.

38.

Opsonization by anti-dsDNA antibodies of apoptotic cells in systemic lupus erythematosus.

Sarmiento LF, Muñoz LE, Chirinos P, Bianco NE, Zabaleta-Lanz ME.

Autoimmunity. 2007 Jun;40(4):337-9.

PMID:
17516223
39.

HCV RNA sequences in eosinophils of chronic HCV-infected patients.

Toro F, Conesa A, Garcia A, Deibis L, Bianco NE, De Sanctis JB.

J Med. 1999;30(3-4):279-88.

PMID:
17312681
40.

Further description of early clinically silent lupus nephritis.

Zabaleta-Lanz ME, Muñoz LE, Tapanes FJ, Vargas-Arenas RE, Daboin I, Barrios Y, Pinto JA, Bianco NE.

Lupus. 2006;15(12):845-51.

PMID:
17211989
41.

Immunophenotype characteristics of peripheral blood mononuclear leukocytes of chronic idiopathic urticaria patients.

Garmendia JV, Zabaleta M, Aldrey O, Rivera H, De Sanctis JB, Bianco NE, Blanca I.

Invest Clin. 2006 Dec;47(4):361-9.

PMID:
17176904
42.

Management of severe sepsis and septic shock: challenges and recommendations.

Gullo A, Bianco N, Berlot G.

Crit Care Clin. 2006 Jul;22(3):489-501, ix. Review.

PMID:
16893735
43.

Excited-state dynamics of (SO2)m clusters.

Dermota TE, Hydutsky DP, Bianco NJ, Castleman AW Jr.

J Phys Chem A. 2005 Sep 22;109(37):8259-67.

PMID:
16834213
44.

Ultrafast dynamics of the SO2(H2O)n cluster system.

Dermota TE, Hydutsky DP, Bianco NJ, Castleman AW Jr.

J Phys Chem A. 2005 Sep 22;109(37):8254-8.

PMID:
16834212
45.

Photoinduced ion-pair formation in the (HI)m(H2O)n cluster system.

Dermota TE, Hydutsky DP, Bianco NJ, Castleman AW.

J Chem Phys. 2005 Dec 1;123(21):214308.

PMID:
16356049
46.

Exosomes derived from genetically modified DC expressing FasL are anti-inflammatory and immunosuppressive.

Kim SH, Bianco N, Menon R, Lechman ER, Shufesky WJ, Morelli AE, Robbins PD.

Mol Ther. 2006 Feb;13(2):289-300. Epub 2005 Nov 7.

47.

Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis.

Kim SH, Lechman ER, Bianco N, Menon R, Keravala A, Nash J, Mi Z, Watkins SC, Gambotto A, Robbins PD.

J Immunol. 2005 May 15;174(10):6440-8.

48.

Estrogen receptor regulation of quinone reductase in breast cancer: implications for estrogen-induced breast tumor growth and therapeutic uses of tamoxifen.

Montano MM, Bianco NR, Deng H, Wittmann BM, Chaplin LC, Katzenellenbogen BS.

Front Biosci. 2005 May 1;10:1440-61. Review.

PMID:
15769636
49.
50.

Stage-specific activity of potential antimalarial compounds measured in vitro by flow cytometry in comparison to optical microscopy and hypoxanthine uptake.

Contreras CE, Rivas MA, Domínguez J, Charris J, Palacios M, Bianco NE, Blanca I.

Mem Inst Oswaldo Cruz. 2004 Mar;99(2):179-84. Epub 2004 Jun 24.

Supplemental Content

Loading ...
Support Center